Antimetabolites: all 7,479 studies that test it

Page 23 of 75. Open to participants first (1,134), then studies with results posted, then the rest; newest registration first within each.

• Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast CancerCompletedNCT00894504Phase 2Results posted
• Phase 1-2 of Azacitidine + Lenalidomide for Previously Untreated Elderly Patients With Acute Myeloid Leukemia (AML)CompletedNCT00890929Phase 1/2Results posted
• Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia SalvageCompletedNCT00890656Phase 2Results posted
• Neoadjuvant Accelerated Short Course Radiation Therapy With Photons and Capecitabine for Resectable Pancreatic CancerTerminatedNCT00889187Phase 1/2Results posted
• Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma SubtypesCompletedNCT00887809Phase 2Results posted
• A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung CancerCompletedNCT00887549Phase 2Results posted
• Controlled Study of Post-transplant Azacitidine for Prevention of Acute Myelogenous Leukemia and Myelodysplastic Syndrome Relapse (VZ-AML-PI-0129)CompletedNCT00887068Phase 3Results posted
• A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast CancerCompletedNCT00885755Phase 2Results posted
• A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic CancerCompletedNCT00882310Phase 2Results posted
• Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic LeukemiaTerminatedNCT00882206Phase 2Results posted
• Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (H-R MDS)CompletedNCT00882102Phase 2Results posted
• Lapatinib and Capecitabine for Second Line Treatment of Pancreas CancerTerminatedNCT00881621Phase 2Results posted
• Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell LymphomaCompletedNCT00878254Phase 2Results posted
• Imaginal Exposure & D-Cycloserine (DCS) for Posttraumatic Stress Disorder (PTSD)TerminatedNCT00875342Not applicableResults posted
• The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)TerminatedNCT00872001Phase 3Results posted
• Study of Pazopanib and Pemetrexed in Advanced Non-small Cell Lung CancerCompletedNCT00871403Phase 2Results posted
• Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With GemzarCompletedNCT00869258Phase 2Results posted
• Capecitabine and Temozolomide for Neuroendocrine CancersCompletedNCT00869050Phase 2Results posted
• GTX Regimen for Biliary CancersTerminatedNCT00868998Phase 2Results posted
• Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal CarcinomaCompletedNCT00868192Phase 2Results posted
• A Study of Induction and Maintenance Treatment of Advanced or Metastatic Non Squamous Non-Small Cell Lung CancerCompletedNCT00867009Phase 2Results posted
• Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic LymphomaCompletedNCT00866749Phase 2Results posted
• Study of Pemetrexed for Second-Line Pancreas CancerTerminatedNCT00864513Phase 2Results posted
• D-Cycloserine Augmentation of Therapy for Pediatric Obsessive-Compulsive DisorderCompletedNCT00864123Phase 2Results posted
• Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung CancerTerminatedNCT00863512Phase 3Results posted
• Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual DiseaseTerminatedNCT00863434Phase 2Results posted
• Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin LymphomaCompletedNCT00863369Phase 1/2Results posted
• A Study of IMC-1121B (Ramucirumab) in Colorectal CancerCompletedNCT00862784Phase 2Results posted
• Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic LeukemiaCompletedNCT00860574Phase 2Results posted
• Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)CompletedNCT00860457Phase 2Results posted
• Alimta Plus Gemcitabine for Advanced SarcomaCompletedNCT00860015Phase 2Results posted
• Trimodal Lung-Sparing Treatment of Pleural MesotheliomaTerminatedNCT00859495Phase 2Results posted
• Eloxatin® Plus Gemcitabine Chemotherapy for MesotheliomaCompletedNCT00859469Phase 2Results posted
• Neoadjuvant Cisplatin, Gemcitabine, Sunitinib Malate + Radical Cystectomy for TCCTerminatedNCT00859339Phase 2Results posted
• Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk MalignanciesCompletedNCT00857389Phase 2Results posted
• Fludarabine Phosphate, Melphalan, Total-Body Irradiation, Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Bone Marrow Failure DisordersCompletedNCT00856388Not applicableResults posted
• Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) PatientsCompletedNCT00851318Phase 3Results posted
• Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) CancersTerminatedNCT00848783Phase 2Results posted
• CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention TrialCompletedNCT00847912Phase 4Results posted
• Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder CancerCompletedNCT00847015Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Taxane-based Chemotherapy as First Line Treatment in Patients With HER-2 Negative Breast CancerCompletedNCT00846027Phase 2Results posted
• Cilengitide and Cetuximab in Combination With Platinum-based Chemotherapy as First-line Treatment for Subjects With Advanced Non Small Cell Lung Cancer (NSCLC)CompletedNCT00842712Phase 2Results posted
• D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic DisorderCompletedNCT00842309Early Phase 1Results posted
• Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric CancerCompletedNCT00842244Phase 1Results posted
• S0919 Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid LeukemiaCompletedNCT00840177Phase 2Results posted
• Clofarabine and Cytarabine in Treating Older Patients With AML or High-Risk MDSCompletedNCT00839982Phase 1/2Results posted
• Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the PancreasCompletedNCT00837031Phase 2Results posted
• Study of IMC-11F8 in Participants With Colorectal CancerCompletedNCT00835185Phase 2Results posted
• Leflunomide 20 mg Tablets Under Fasting ConditionsCompletedNCT00834418Phase 1Results posted
• Leflunomide 20 mg Tablets, Non-FastingCompletedNCT00834405Phase 1Results posted
• Neoadjuvant Gemcitabine, Docetaxel, and Capecitabine in Combination With Stereotactic RadiosurgeryTerminatedNCT00833859Phase 2Results posted
• Dose Optimization of Infliximab in Moderate to Severe Plaque Psoriasis (Study P05315)TerminatedNCT00833053Phase 3Results posted
• Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree CancersTerminatedNCT00832637Phase 2Results posted
• Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)CompletedNCT00831766Phase 1/2Results posted
• Neo-adjuvant Chemoradiation With Oxaliplatin/5-FU in Rectal CancerCompletedNCT00831181Phase 2Results posted
• Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLCCompletedNCT00828841Phase 2Results posted
• Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic CancerTerminatedNCT00827099Phase 2Results posted
• Phase II Study of TAS-109 to Treat Advanced Colorectal CancerTerminatedNCT00824161Phase 2Results posted
• Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and ThymoglobulinCompletedNCT00822770Phase 1/2Results posted
• Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)CompletedNCT00822094Phase 2Results posted
• Gemzar, Cisp, Sunitinib Urothelial CaCompletedNCT00821327Phase 2Results posted
• Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00820898Phase 2Results posted
• A Study of the Efficacy of Canakinumab in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (Core Study) and a Long-term Study of the Efficacy and Safety of Canakinumab in Patients With Gout (Extension Study)CompletedNCT00819585Phase 2Results posted
• Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic CancerTerminatedNCT00818961Phase 2Results posted
• Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid LeukemiaTerminatedNCT00814164Phase 2Results posted
• Efficacy of Methotrexate in Myasthenia GravisCompletedNCT00814138Phase 2Results posted
• Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)CompletedNCT00813124Phase 2Results posted
• A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast CancerCompletedNCT00811135Phase 2Results posted
• Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic CancerCompletedNCT00810719Phase 2Results posted
• A Study of Tocilizumab and Methotrexate Treatment Strategies (Adding Tocilizumab to Methotrexate Versus Switching to Tocilizumab) in Patients With Active Rheumatoid Arthritis With Inadequate Response to Prior Methotrexate TreatmentCompletedNCT00810199Phase 3Results posted
• Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCYCompletedNCT00809276Phase 1/2Results posted
• Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response AssessmentCompletedNCT00807573Phase 2Results posted
• Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLCCompletedNCT00806819Phase 3Results posted
• Phase I/IIa Trial to Investigate BI 6727 (Volasertib) as Monotherapy or in Combination With Cytarabine in Acute Myeloid LeukaemiaCompletedNCT00804856Phase 2Results posted
• Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell TransplantationCompletedNCT00803010Phase 2Results posted
• Double Cord Blood Transplant for Patients With Malignant and Non-malignant DisordersTerminatedNCT00801931Phase 1/2Results posted
• High-dose Sequential Chemoimmunotherapy for B-cell Lymphomas With Central Nervous System InvolvementCompletedNCT00801216Phase 2Results posted
• Busulfan and Fludarabine Followed by Post-transplant CyclophosphamideCompletedNCT00800839Phase 2Results posted
• A Study of Xeloda (Capecitabine) Plus Radiotherapy in Participants With Locally Advanced Rectal CancerCompletedNCT00796718Phase 2Results posted
• Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood TransplantCompletedNCT00796068Phase 2Results posted
• A Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic SyndromeCompletedNCT00796003Phase 1Results posted
• Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic MalignanciesCompletedNCT00795132Phase 2Results posted
• Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00795002Phase 2Results posted
• Fludarabine, Cyclophosphamide, and Rituximab - High Dose FrontlineCompletedNCT00794820Phase 2Results posted
• A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced CarcinomaTerminatedNCT00794417Phase 1/2Results posted
• A Controlled Study of Uric Acid on the Progression of IgA NephropathyCompletedNCT00793585Not applicableResults posted
• S0720: Adjuvant Therapy Based on Gene Expression in Stage IA and IB Non-Small Cell Lung CancerCompletedNCT00792701Phase 2Results posted
• Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic DisorderCompletedNCT00790868Phase 2Results posted
• S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile DuctCompletedNCT00789958Phase 2Results posted
• Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic CancerCompletedNCT00789776Phase 1/2Results posted
• A Study of Induction and Maintenance Treatment of Advanced Non-squamous Non-Small Cell Lung CancerCompletedNCT00789373Phase 3Results posted
• Trial of CPX-351 in Newly Diagnosed Elderly AML PatientsCompletedNCT00788892Phase 2Results posted
• Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver CancerTerminatedNCT00787787Phase 2Results posted
• Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological CancerCompletedNCT00787761Phase 2Results posted
• Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric CarcinomaCompletedNCT00780494Phase 2Results posted
• D-Cycloserine and Cue Exposure in Cocaine-Dependent IndividualsCompletedNCT00780442Phase 2Results posted
• Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory LeukemiaTerminatedNCT00780143Phase 1/2Results posted
• A Dose-escalation Study of MK-8776 (SCH 900776) With and Without Gemcitabine in Participants With Solid Tumors or Lymphoma (MK-8776-002/P05248)CompletedNCT00779584Phase 1Results posted
• Utility of Intravitreal Methotrexate in Diabetic Macular Edema Resistant to Conventional TherapiesTerminatedNCT00779142Not applicableResults posted
• Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)CompletedNCT00778375Phase 2Results posted

← Antimetabolites overview